Enrofloxacin, Antibiotic for Culture Media Use Only

CAS : 93106-60-6

Ref. 3D-J-200240

Informations sur le produit

• Nom: Enrofloxacin, Antibiotic for Culture Media Use Only
• Synonymes: 1,4-Dihydro-1-Cyclopropyl-7-(4-Ethyl-1-Piperazinyl)-6-Fluoro-4-Oxo-3-Quinoli, 1-Cyclopropyl-6-fluoro-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-Cyclopropyl-7-(4-ethyl-piperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid, 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-, Alsir, BAY-Vp 2674, Bayrocin, Baytril, Biofloxavet, Cfpq, Enflocyna Sol, Enrocin, Enrodac, Enrofan, Enroflon, Enrofloxacine Base Cvp2005, Enrogil, Enrovet, Enroxil, Fortius, N'-Ethylciprofloxacin, N-Ethyl ciprofloxacin, Pd 160788

Description

Enrofloxacin is a rapidly bactericidal antibiotic, that inhibits bacterial growth by binding to the 50S ribosomal subunit and blocking protein synthesis, thereby preventing the bacteria from making new proteins. Enrofloxacin also has strong activity against gram-positive bacteria, including Clostridium perfringens which is an anaerobic bacterium that causes food-borne illness. This antibiotic is used for the treatment of acute bacterial infections in humans, such as, skin or soft tissue infections, urinary tract infections (UTIs) and septicemia (bloodstream infection). Enrofloxacin has shown excellent bioavailability with high serum protein binding capacity. Additionally, it has good efficacy against clinical isolates of Escherichia coli and Klebsiella pneumoniae. Enrofloxacin can be used effective in treatments for Pseudomonas aeruginosa and Enterobacter species.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 359.39 g/mol
• Formule: C₁₉H₂₂FN₃O₃
• Degré de pureté: (Hplc) Min. 98.5%